NAD and Vascular Dysfunction: From Mechanisms to Therapeutic Opportunities

Overview

Journal J Lipid Atheroscler

Date 2022 Jun 3

PMID 35656147

Authors

Mahmoud Abdellatif

Heiko Bugger

Guido Kroemer

Simon Sedej

Affiliations

Soon will be listed here.

Abstract

Nicotinamide adenine dinucleotide (NAD) is an essential and pleiotropic coenzyme involved not only in cellular energy metabolism, but also in cell signaling, epigenetic regulation, and post-translational protein modifications. Vascular disease risk factors are associated with aberrant NAD metabolism. Conversely, the therapeutic increase of NAD levels through the administration of NAD precursors or inhibitors of NAD-consuming enzymes reduces chronic low-grade inflammation, reactivates autophagy and mitochondrial biogenesis, and enhances oxidative metabolism in vascular cells of humans and rodents with vascular pathologies. As such, NAD has emerged as a potential target for combatting age-related cardiovascular and cerebrovascular disorders. This review discusses NAD-regulated mechanisms critical for vascular health and summarizes new advances in NAD research directly related to vascular aging and disease, including hypertension, atherosclerosis, coronary artery disease, and aortic aneurysms. Finally, we enumerate challenges and opportunities for NAD repletion therapy while anticipating the future of this exciting research field, which will have a major impact on vascular medicine.

Citing Articles

Erythrocyte nicotinamide adenine dinucleotide concentration is enhanced by systematic sports participation.

Pospieszna B, Kusy K, Slominska E, Zielinski J, Ciekot-Soltysiak M BMC Sports Sci Med Rehabil. 2024; 16(1):216.

PMID: 39407226 PMC: 11476931. DOI: 10.1186/s13102-024-00999-y.

Improved Physical Performance Parameters in Patients Taking Nicotinamide Mononucleotide (NMN): A Systematic Review of Randomized Control Trials.

Wen J, Syed B, Kim S, Shehabat M, Ansari U, Razick D Cureus. 2024; 16(8):e65961.

PMID: 39221308 PMC: 11365583. DOI: 10.7759/cureus.65961.

An Emerging Role of Micro- and Nanoplastics in Vascular Diseases.

Lee S, Yoon H, Kim D, Jeong T, Park Y Life (Basel). 2024; 14(2).

PMID: 38398764 PMC: 10890539. DOI: 10.3390/life14020255.

Intestinal microbiota and metabolome perturbations in ischemic and idiopathic dilated cardiomyopathy.

Wang Y, Xie Y, Mahara G, Xiong Y, Xiong Y, Zheng Q J Transl Med. 2024; 22(1):89.

PMID: 38254195 PMC: 10804607. DOI: 10.1186/s12967-023-04605-6.

Hallmarks of cardiovascular ageing.

Abdellatif M, Rainer P, Sedej S, Kroemer G Nat Rev Cardiol. 2023; 20(11):754-777.

PMID: 37193857 DOI: 10.1038/s41569-023-00881-3.

References

Mateuszuk L, Campagna R, Kutryb-Zajac B, Kus K, Slominska E, Smolenski R . Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside. Biochem Pharmacol. 2020; 178:114019. DOI: 10.1016/j.bcp.2020.114019. View

Escande C, Nin V, Price N, Capellini V, Gomes A, Barbosa M . Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2012; 62(4):1084-93. PMC: 3609577. DOI: 10.2337/db12-1139. View

Michiels C, Fransen P, De Munck D, De Meyer G, Martinet W . Defective autophagy in vascular smooth muscle cells alters contractility and Ca²⁺ homeostasis in mice. Am J Physiol Heart Circ Physiol. 2015; 308(6):H557-67. DOI: 10.1152/ajpheart.00659.2014. View

Landray M, Haynes R, Hopewell J, Parish S, Aung T, Tomson J . Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014; 371(3):203-12. DOI: 10.1056/NEJMoa1300955. View

Boslett J, Reddy N, Alzarie Y, Zweier J . Inhibition of CD38 with the Thiazoloquin(az)olin(on)e 78c Protects the Heart against Postischemic Injury. J Pharmacol Exp Ther. 2019; 369(1):55-64. PMC: 6413770. DOI: 10.1124/jpet.118.254557. View

Sukhodub A, Du Q, Jovanovic S, Jovanovic A . Nicotinamide-rich diet protects the heart against ischaemia-reperfusion in mice: a crucial role for cardiac SUR2A. Pharmacol Res. 2010; 61(6):564-70. PMC: 2859200. DOI: 10.1016/j.phrs.2010.01.008. View

Grunewald M, Kumar S, Sharife H, Volinsky E, Gileles-Hillel A, Licht T . Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science. 2021; 373(6554). DOI: 10.1126/science.abc8479. View

Ljubojevic-Holzer S, Kraler S, Djalinac N, Abdellatif M, Voglhuber J, Schipke J . Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling. Cardiovasc Res. 2021; 118(6):1492-1505. PMC: 9074988. DOI: 10.1093/cvr/cvab112. View

Guse A . Regulation of calcium signaling by the second messenger cyclic adenosine diphosphoribose (cADPR). Curr Mol Med. 2004; 4(3):239-48. DOI: 10.2174/1566524043360771. View

10.

Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto J, Bagi Z, Ballabh P . Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009; 297(5):H1876-81. PMC: 2781360. DOI: 10.1152/ajpheart.00375.2009. View

11.

Zhang H, Dai Y, Zhang C, Omondi A, Ghosh A, Khanra I . Sirtuins family as a target in endothelial cell dysfunction: implications for vascular ageing. Biogerontology. 2020; 21(5):495-516. DOI: 10.1007/s10522-020-09873-z. View

12.

Nencioni A, da Silva R, Fraga-Silva R, Steffens S, Fabre M, Bauer I . Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. Thromb Haemost. 2013; 111(2):308-22. DOI: 10.1160/TH13-07-0531. View

13.

Digby J, Martinez F, Jefferson A, Ruparelia N, Chai J, Wamil M . Anti-inflammatory effects of nicotinic acid in human monocytes are mediated by GPR109A dependent mechanisms. Arterioscler Thromb Vasc Biol. 2012; 32(3):669-76. PMC: 3392598. DOI: 10.1161/ATVBAHA.111.241836. View

14.

Gorenne I, Kumar S, Gray K, Figg N, Yu H, Mercer J . Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis. Circulation. 2012; 127(3):386-96. DOI: 10.1161/CIRCULATIONAHA.112.124404. View

15.

Weiss R, Schilling E, Grahnert A, Kolling V, Dorow J, Ceglarek U . Nicotinamide: a vitamin able to shift macrophage differentiation toward macrophages with restricted inflammatory features. Innate Immun. 2015; 21(8):813-26. DOI: 10.1177/1753425915602545. View

16.

Liu L, Wang Q, Zhao B, Wu Q, Wang P . Exogenous nicotinamide adenine dinucleotide administration alleviates ischemia/reperfusion-induced oxidative injury in isolated rat hearts via Sirt5-SDH-succinate pathway. Eur J Pharmacol. 2019; 858:172520. DOI: 10.1016/j.ejphar.2019.172520. View

17.

van der Hoorn J, de Haan W, Berbee J, Havekes L, Jukema J, Rensen P . Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice. Arterioscler Thromb Vasc Biol. 2008; 28(11):2016-22. DOI: 10.1161/ATVBAHA.108.171363. View

18.

Knip M, Douek I, MOORE W, Gillmor H, McLean A, Bingley P . Safety of high-dose nicotinamide: a review. Diabetologia. 2000; 43(11):1337-45. DOI: 10.1007/s001250051536. View

19.

Romani M, Hofer D, Katsyuba E, Auwerx J . Niacin: an old lipid drug in a new NAD dress. J Lipid Res. 2019; 60(4):741-746. PMC: 6446705. DOI: 10.1194/jlr.S092007. View

20.

Zhai X, Han W, Wang M, Guan S, Qu X . Exogenous supplemental NAD+ protect myocardium against myocardial ischemic/reperfusion injury in swine model. Am J Transl Res. 2019; 11(9):6066-6074. PMC: 6789262. View